KPTI vs NXPI · rev $68.5M vs P/E 29, rev $12.27B
Karyopharm Therapeutics Inc (KPTI) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
KPTI currently screens at market cap $205.6M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the KPTI and NXPI stock pages for the full models.
Not investment advice.